Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: A factor in diabetic retinopathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 241, Issue 1, 2003, Pages 56-62

  Xu, Xun ^a   Li, Zhiping ^a   Luo, Dawei ^a   Huang, Yufeng ^a   Zhu, Jianfeng ^a   Wang, Xiaojue ^a   Hu, Honghiu ^a   Patrick, C P ^b  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b NONE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RAT; RAT STRAIN; RETINA BLOOD VESSEL; RETINA CAPILLARY; TISSUE DISTRIBUTION; WILD TYPE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FLUORESCENCE ANGIOGRAPHY; GLYCOSYLATION; INTRAVENOUS DRUG ADMINISTRATION; PATHOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; CELL COUNT; DIABETIC RETINOPATHY; FLUORESCEIN ANGIOGRAPHY; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; INJECTIONS, INTRAVENOUS; PERICYTES; RATS; RATS, SPRAGUE-DAWLEY; RETINAL VESSELS;

EID: 0037263160     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-002-0575-7     Document Type: Article

References (15)

1. Bierhaus A (1997) Advanced glycation end products (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96:2262-2264
2. Ferris FL, Davis MD, Aiello LM (1999) Drug therapy: treatment of diabetic retinopathy. Review articles. N Engl J Med 341:667-678
3. Hammes HP, Wellensiek B, Kloting I, et al (1998) The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster. Diabetologia 41:165-170
4. Heidland A, Sebekova K, Schinzel R (2001) Advanced glycation end products and the progressive course of renal disease. Am J Kidney Dis 38 [4 Suppl 1]:S100-106
5. Huang Y, Lin S (1999) Inhibition of nonenzymatic glycation in renal glomeruli of experimental diabetes by Benazepril. Chin J Nephrol 15:241-244
6. Klein R, Klein BE, Moss SE (1989) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: a review. Diabetes Metab Rev 5:559-570
7. Makita Z, Vlassara H, Cerami A, et al (1992) Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138
8. Murata T, Nagai R, Ishibashi T, Inomata H, Ikeda K, Horiuchi S (1997) The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas [J]. Diabetologia 40:764-769
9. Rodriguez J, Sanchez R, Munoz B, et al (2002) Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology 109:737-743
10. Vlassara H (1994) Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 124:19-30
11. Vlassara H, Palace MR (2002) Diabetes and advanced glycation end products. J Intern Med 251:87-101
12. Xu X, Zhang X (1996) Surgical treatment of proliferative diabetic retinopathy. Chin J Pract Ophthalmol 14:450-454
13. Yang Y, He S (1997) An observation on early morphological changes in retinal microvascular vessels in diabetic rats. Chin J Ophthalmol 33:230-232
14. Yim MB, Yim HS, Lee C, et al (2001) Protein glycation: creation of catalytic sites for free radical generation. Ann N Y Acad Sci 928:48-53
15. Zhang H (1993) The ocular microcirculation and its diseases, 1st edn. (in Chinese) Chinese Union Medical College Press, Beijing, pp 19-21